Evolus Advances Mid-Face Filler Toward FDA Approval
Evolus has submitted the final module of its PMA application to the FDA for Evolysse Sculpt, an injectable HA gel for mid-face volume restoration.
Evolus has submitted the final module of its PMA application to the FDA for Evolysse Sculpt, an injectable HA gel for mid-face volume restoration.
The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.